Skip to main content
. 2020 Jul 6;13(3):14. doi: 10.3892/mco.2020.2084

Figure 1.

Figure 1

Response rate of NDLS based chemotherapy in patients with gastric and gastroesophageal adenocarcinoma in (A) neoadjuvant (n=17) and (B) metastatic (n=18) settings. CR, complete response; DCR, disease control rate; NDLS, nanosomal docetaxel lipid suspension; ORR, overall response rate; PR, partial response; SD, stable disease.